PMID: 26186947

Mulugeta S, Nureki S, Beers MF
Lost after translation: insights from pulmonary surfactant for understanding the role of alveolar epithelial dysfunction and cellular quality control in fibrotic lung disease.
Am J Physiol Lung Cell Mol Physiol. 2015 Sep 15;309(6):L507-25. doi: 10.1152/ajplung.00139.2015. Epub 2015 Jul 17., [PubMed]
Sentences
No. Mutations Sentence Comment
134 ABCA1 p.Gln188Leu
X
ABCA1 p.Gln188Leu 26186947:134:97
status: NEW
view ABCA1 p.Gln188Leu details
Shortly after, a second report described a different SFTPC mutation resulting in substitution of glutamine for leucine at position 188 of the SP-C propeptide (SP-CL188Q ) in a large kindred of whom the biopsies of 11 adults showed IPF/UIP patterns and nonspecific interstitial pneumonia (NSIP) patterns were present in three children. Login to comment
267 ABCA3 p.Leu101Pro
X
ABCA3 p.Leu101Pro 26186947:267:2162
status: NEW
view ABCA3 p.Leu101Pro details
ABCA3 p.Asn568Asp
X
ABCA3 p.Asn568Asp 26186947:267:2626
status: NEW
view ABCA3 p.Asn568Asp details
ABCA3 p.Glu292Val
X
ABCA3 p.Glu292Val 26186947:267:2599
status: NEW
view ABCA3 p.Glu292Val details
ABCA3 p.Gly1221Ser
X
ABCA3 p.Gly1221Ser 26186947:267:2239
status: NEW
view ABCA3 p.Gly1221Ser details
ABCA3 p.Leu1553Pro
X
ABCA3 p.Leu1553Pro 26186947:267:2263
status: NEW
view ABCA3 p.Leu1553Pro details
ABCA3 p.Leu1580Pro
X
ABCA3 p.Leu1580Pro 26186947:267:2700
status: NEW
view ABCA3 p.Leu1580Pro details
ABCA3 p.Gln1591Pro
X
ABCA3 p.Gln1591Pro 26186947:267:2286
status: NEW
view ABCA3 p.Gln1591Pro details
ABCA3 p.Leu982Pro
X
ABCA3 p.Leu982Pro 26186947:267:2214
status: NEW
view ABCA3 p.Leu982Pro details
ABCA3 p.Glu690Lys
X
ABCA3 p.Glu690Lys 26186947:267:2639
status: NEW
view ABCA3 p.Glu690Lys details
ABCA3 p.Arg280Cys
X
ABCA3 p.Arg280Cys 26186947:267:2187
status: NEW
view ABCA3 p.Arg280Cys details
ABCA3 p.Thr1173Arg
X
ABCA3 p.Thr1173Arg 26186947:267:2674
status: NEW
view ABCA3 p.Thr1173Arg details
ABCA3 p.Asp253His
X
ABCA3 p.Asp253His 26186947:267:2574
status: NEW
view ABCA3 p.Asp253His details
ABCA3 p.Arg43Leu
X
ABCA3 p.Arg43Leu 26186947:267:2550
status: NEW
view ABCA3 p.Arg43Leu details
ABCA3 p.Thr1114Met
X
ABCA3 p.Thr1114Met 26186947:267:2652
status: NEW
view ABCA3 p.Thr1114Met details
Summary of reported phenotypic features for surfactant component mutations Mutation (Domain) Clinical Diagnosis Lung Phenotype (in vivo) Subcellular Localization Trafficking Cellular Responses (in vitro) References SFTPA2 F198S (CRD) G231V (CRD) Familial pulmonary fibrosis Total BAL [SP-A] Normal ER retention Intracellular aggregation Not secreted (af9;) ER stress, cleared by ERAD (af9;) TGFbeta1 elaboration 99, 100, 175 SFTPC Group A1 èc;Exon4 (BRICHOS) L188Q (BRICHOS) G100S (BRICHOS) NSIP (Children) IPF/UIP (Adult) Absence of mature SP-C (humans) Arrested lung development (mice) ER stress (humans; mice) 1Sensitivity to bleomycin (mice) Epithelial cytotoxicity ER retention&#a1; aggresomes Intracellular aggregates ERAD requires Erdj 4/5 MG132 blocks degradation 4-PBA improves aggregates (af9;) ER stress (af9;) Apoptosis (af9;) Incomplete or absent proSP-C processing (af9;) IL-8/TGFbeta1 expression (af9;) Polyubiquitinated isoforms 21, 39, 97, 98, 100, 111, 112, 116, 117, 120, 153, 159, 160, 173, 193 Group A2 L110R (BRICHOS) P115L (BRICHOS) A116D (BRICHOS) Unspecified ILD Unspecified ILD Unspecified chILD Phenotype not reported EEA-1 (af9;); Syntaxin2 (afa;) Intracellular aggregation 2 PC secretion (af9;) Aberrant processing, 2 cell viability 1 HSP response (af9;) Congo red aggregates 160, 193 Group B1 E66K (Linker) I73T (Linker) NSIP/PAP (Child) IPF/UIP (Adult) 1 Phospholipid; 1SP-A, PAS positive staining Biopsy: PM and EE localization Misprocessed SP-C (BAL) Misprocessed SP-B (BAL) Plasma membrane&#a1;EE&#a1;LE/MVB (af9;) Aberrantly processed protein (af9;) Late autophagy block 2 Mitophagy 1 Mysfunctional mitochondria 1, 19, 24, 26, 49, 116, 118, 128, 152 Group B2 èc;91-93 (Non-BRICHOS) NSIP/PAP 2 BAL SP-B 1 BAL SP-A 2 Surfactant surface tension (af9;) Intracellular aggregates (af9;) Congo red staining Plasma membraneߥ EEA1 (af9;) compartmentsߥ Not reported 55, 181 Group C P30L (NH2-terminal) Unspecified ILD Phenotype not reported (af9;) ER retention 1 Bip expression (af9;) Polyubiquitinated isoforms 13, 116, 160 ABCA3 Group I (Trafficking Defective) L101P (1st luminal loop) R280C (1st cytosolic loop) L982P (3rd luminal loop) G1221S (11th TM domain) L1553P (COOH-terminal) Q1591P (COOH-terminal) Surfactant deficiency* RDS* chILDߤ Phenotype not reported Phenotype not reported Phenotype not reported (af9;) ER retention Non-LRO cytosolic vesicles (af9;) ER stress 30, 31, 103, 147, 172, 177 Group II (Functionally Defective) R43L (1st luminal loop) D253H (1st luminal loop) E292V (1st cytosolic loop) N568D (ABC1) E690K (ABC1) T1114M (8thTM domain) T1173R (1st luminal loop) L1580P (COOH-terminal) Surfactant deficiency* RDS* chILD (CPI)ߤ Reduced SP-B and SP-C (afa;) ER retention Lysosomes or LROs (normal) Impaired lipid transport Impaired ATP hydrolysis Impaired ATP binding Abnormal LBs 1 IL8 secretion 20, 25, 103, 104, 147, 148, 177 *Seen with homozygous or compound heterozygous ABCA3 expression; ߤfound with heterozugous ABCA3 expression. Login to comment
300 ABCA3 p.Ser198Phe
X
ABCA3 p.Ser198Phe 26186947:300:78
status: NEW
view ABCA3 p.Ser198Phe details
Resulting from the substitution of valine for glycine at codon 231 (G231V) or serine for phenylalanine at codon 198 (F198S) in the CRD of the SP-A protein, when expressed in lung cell lines or primary murine AT2 cells, the resulting mutant SFTPA2 protein products were proximally retained, failed to be secreted, and activated the UPR (99). Login to comment
304 ABCA3 p.Leu101Pro
X
ABCA3 p.Leu101Pro 26186947:304:122
status: NEW
view ABCA3 p.Leu101Pro details
ABCA3 p.Gly1221Ser
X
ABCA3 p.Gly1221Ser 26186947:304:152
status: NEW
view ABCA3 p.Gly1221Ser details
ABCA3 p.Leu1553Pro
X
ABCA3 p.Leu1553Pro 26186947:304:136
status: NEW
view ABCA3 p.Leu1553Pro details
ABCA3 p.Gln1591Pro
X
ABCA3 p.Gln1591Pro 26186947:304:144
status: NEW
view ABCA3 p.Gln1591Pro details
ABCA3 p.Leu982Pro
X
ABCA3 p.Leu982Pro 26186947:304:129
status: NEW
view ABCA3 p.Leu982Pro details
Although not restricted to any particular domain, functional characterization of a subgroup of ABCA3 mutations (including L101P, L982P, L1553P, Q1591P, G1221S) by transient or stable expression results in their total or partial retention in the ER (30, 103). Login to comment
337 ABCA3 p.Glu292Val
X
ABCA3 p.Glu292Val 26186947:337:102
status: NEW
view ABCA3 p.Glu292Val details
In one adult FPF kindred all carrying the same SFTPC mutation, a functional genetic variant in ABCA3 (E292V) also found in the previous pediatric study appeared to also affect disease penetrance, suggesting interplay between the two genotypes (37), not surprising given their overlapping biology within the AT2 cell. Login to comment